                         SEQUENCE LISTING

<110>  Consejo Superior de Investigaciones Cientficas (CSIC)
 
<120>  ANTIHYPERTENSIVE PEPTIDES FROM OLIVE OIL

<130>  EP1641.1160

<160>  16    

<170>  PatentIn version 3.5

<210>  1
<211>  7
<212>  PRT
<213>  Olea europaea

<400>  1

Arg Asp Gly Gly Tyr Cys Cys 
1               5           


<210>  2
<211>  9
<212>  PRT
<213>  Olea europaea

<400>  2

Tyr Tyr Cys Pro Ala Asp Cys Pro Ser 
1               5                   


<210>  3
<211>  8
<212>  PRT
<213>  Olea europaea

<400>  3

Tyr Gly Cys Gly Cys Asp Pro Leu 
1               5               


<210>  4
<211>  6
<212>  PRT
<213>  Olea europaea

<400>  4

Leu Glu Glu Phe Cys Cys 
1               5       


<210>  5
<211>  7
<212>  PRT
<213>  Olea europaea

<400>  5

His Cys Gly Cys Asn Thr His 
1               5           


<210>  6
<211>  7
<212>  PRT
<213>  Olea europaea

<400>  6

Trp Ala Ala Gly Tyr Cys Cys 
1               5           


<210>  7
<211>  8
<212>  PRT
<213>  Olea europaea

<400>  7

Cys Cys Gly Asn Ala Val Pro Gln 
1               5               


<210>  8
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Carrier

<400>  8

Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   


<210>  9
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Carrier

<400>  9

Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10      


<210>  10
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Carrier

<400>  10

Cys Gly Ile Ser Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10                  15  


<210>  11
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Carrier

<400>  11

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


<210>  12
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Carrier

<400>  12

Lys Phe Val Arg Ser Arg Arg Pro Arg Thr Ala Ser Cys Ala Leu Ala 
1               5                   10                  15      


Phe Val Asn 
            


<210>  13
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Carrier

<400>  13

Ser Cys Ala Leu Ala Phe Val Asn 
1               5               


<210>  14
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Marker

<400>  14

Tyr Thr Asp Ile Glu Met Asn Arg Leu Gly Lys 
1               5                   10      


<210>  15
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Marker

<400>  15

Ala His Gly His Arg Pro 
1               5       


<210>  16
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Marker

<400>  16

Pro Ile His Asp His Asp His Pro His Leu Val Ile His Ser 
1               5                   10                  


